Axa’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-803,954
| Closed | -$123M | – | 588 |
|
|
2025
Q2 | $123M | Buy |
803,954
+8,095
| +1% | +$1.24M | 0.35% | 58 |
|
|
2025
Q1 | $132M | Buy |
795,859
+30,308
| +4% | +$4.74M | 0.43% | 53 |
|
|
2024
Q4 | $111M | Buy |
765,551
+73,756
| +11% | +$11.4M | 0.34% | 60 |
|
|
2024
Q3 | $112M | Buy |
691,795
+25,876
| +4% | +$4.12M | 0.33% | 62 |
|
|
2024
Q2 | $97.3M | Sell |
665,919
-107,067
| -14% | -$15.9M | 0.29% | 67 |
|
|
2024
Q1 | $122M | Sell |
772,986
-285,219
| -27% | -$45.4M | 0.37% | 58 |
|
|
2023
Q4 | $166M | Buy |
1,058,205
+129,923
| +14% | +$19.9M | 0.53% | 34 |
|
|
2023
Q3 | $145M | Sell |
928,282
-64,321
| -6% | -$10.6M | 0.51% | 38 |
|
|
2023
Q2 | $164M | Buy |
992,603
+111,370
| +13% | +$18M | 0.55% | 33 |
|
|
2023
Q1 | $137M | Sell |
881,233
-90,941
| -9% | -$14.7M | 0.47% | 39 |
|
|
2022
Q4 | $172M | Buy |
972,174
+80,349
| +9% | +$13.9M | 0.62% | 24 |
|
|
2022
Q3 | $146M | Sell |
891,825
-84,648
| -9% | -$14.3M | 0.57% | 27 |
|
|
2022
Q2 | $173M | Sell |
976,473
-180,398
| -16% | -$32.1M | 0.64% | 22 |
|
|
2022
Q1 | $205M | Buy |
1,156,871
+4,880
| +0.4% | +$830K | 0.58% | 26 |
|
|
2021
Q4 | $197M | Buy |
1,151,991
+155,059
| +16% | +$25.4M | 0.5% | 32 |
|
|
2021
Q3 | $161M | Buy |
996,932
+11,201
| +1% | +$1.91M | 0.45% | 42 |
|
|
2021
Q2 | $162M | Sell |
985,731
-19,526
| -2% | -$3.23M | 0.46% | 40 |
|
|
2021
Q1 | $165M | Sell |
1,005,257
-218,721
| -18% | -$35.4M | 0.5% | 34 |
|
|
2020
Q4 | $193M | Buy |
1,223,978
+22,167
| +2% | +$3.27M | 0.6% | 23 |
|
|
2020
Q3 | $179M | Sell |
1,201,811
-7,489
| -0.6% | -$1.11M | 0.65% | 23 |
|
|
2020
Q2 | $170M | Sell |
1,209,300
-53,899
| -4% | -$7.85M | 0.67% | 22 |
|
|
2020
Q1 | $166M | Buy |
1,263,199
+269,496
| +27% | +$38.2M | 0.83% | 16 |
|
|
2019
Q4 | $145M | Sell |
993,703
-42,337
| -4% | -$5.74M | 0.59% | 27 |
|
|
2019
Q3 | $134M | Buy |
1,036,040
+14,200
| +1% | +$1.87M | 0.53% | 27 |
|
|
2019
Q2 | $142M | Sell |
1,021,840
-3,161
| -0.3% | -$438K | 0.56% | 26 |
|
|
2019
Q1 | $143M | Sell |
1,025,001
-81,048
| -7% | -$10.9M | 0.56% | 24 |
|
|
2018
Q4 | $143M | Sell |
1,106,049
-330,883
| -23% | -$46.2M | 0.62% | 19 |
|
|
2018
Q3 | $199M | Sell |
1,436,932
-249,757
| -15% | -$33.2M | 0.73% | 16 |
|
|
2018
Q2 | $205M | Sell |
1,686,689
-148,967
| -8% | -$18.6M | 0.78% | 14 |
|
|
2018
Q1 | $235M | Sell |
1,835,656
-24,648
| -1% | -$3.33M | 0.94% | 7 |
|
|
2017
Q4 | $260M | Buy |
1,860,304
+142,757
| +8% | +$19.9M | 1.02% | 6 |
|
|
2017
Q3 | $223M | Sell |
1,717,547
-245,770
| -13% | -$32.6M | 0.96% | 8 |
|
|
2017
Q2 | $260M | Sell |
1,963,317
-385,039
| -16% | -$49.1M | 1.18% | 2 |
|
|
2017
Q1 | $292M | Sell |
2,348,356
-192,719
| -8% | -$23M | 1.32% | 2 |
|
|
2016
Q4 | $293M | Sell |
2,541,075
-399,223
| -14% | -$46.1M | 1.37% | 2 |
|
|
2016
Q3 | $347M | Buy |
2,940,298
+51,256
| +2% | +$6.22M | 1.53% | 3 |
|
|
2016
Q2 | $350M | Sell |
2,889,042
-352,923
| -11% | -$40.1M | 1.56% | 3 |
|
|
2016
Q1 | $351M | Sell |
3,241,965
-99,410
| -3% | -$10.3M | 1.57% | 3 |
|
|
2015
Q4 | $343M | Sell |
3,341,375
-598,681
| -15% | -$60.2M | 1.5% | 3 |
|
|
2015
Q3 | $368M | Buy |
3,940,056
+16,520
| +0.4% | +$1.6M | 1.51% | 7 |
|
|
2015
Q2 | $382M | Buy |
3,923,536
+398,901
| +11% | +$39.9M | 1.53% | 4 |
|
|
2015
Q1 | $355M | Buy |
3,524,635
+1,278,648
| +57% | +$130M | 1.46% | 5 |
|
|
2014
Q4 | $235M | Buy |
2,245,987
+133,046
| +6% | +$14M | 0.94% | 11 |
|
|
2014
Q3 | $225M | Buy |
2,112,941
+5,879
| +0.3% | +$610K | 0.96% | 10 |
|
|
2014
Q2 | $220M | Sell |
2,107,062
-67,860
| -3% | -$6.86M | 0.92% | 11 |
|
|
2014
Q1 | $214M | Sell |
2,174,922
-98,419
| -4% | -$9.12M | 0.93% | 14 |
|
|
2013
Q4 | $208M | Sell |
2,273,341
-6,082
| -0.3% | -$561K | 0.93% | 14 |
|
|
2013
Q3 | $198M | Buy |
2,279,423
+126,171
| +6% | +$11.3M | 0.97% | 16 |
|
|
2013
Q2 | $185M | Buy |
+2,153,252
| New | +$183M | 0.98% | 17 |
|
Other funds holding JNJ
Axa's JNJ Position: Q3 2025 in Review
Axa sold out of Johnson & Johnson (JNJ) in Q3 2025, closing a stake of 803,954 shares — an estimated $123M sold.
Axa first reported a position in JNJ in Q2 2013 and held it in 49 quarters. The position peaked at $382M in Q2 2015. 4,188 funds tracked by Wall St. Rank hold JNJ as of Q3 2025.
- Axa reported no remaining Johnson & Johnson position as of Q3 2025 after selling out during the quarter.
- Axa sold 803,954 Johnson & Johnson shares in Q3 2025, an estimated $123M.
- Axa first reported a position in Johnson & Johnson in Q2 2013 and held it in 49 quarters.
- Axa's Johnson & Johnson position peaked at $382M in Q2 2015.
- 4,188 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2025.
Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.